What is the appropriate work‑up and treatment for anemia in a 65‑year‑old paraplegic African‑American male residing in a nursing home with protein‑calorie malnutrition and laboratory findings of hemoglobin 10.3 g/dL, hematocrit 32.5 %, mean corpuscular hemoglobin concentration 31.6 g/dL, and red cell distribution width 15.5 %?

Work‑up and Treatment of Anemia in a 65‑Year‑Old Paraplegic Nursing‑Home Resident with Protein‑Calorie Malnutrition

This patient requires immediate oral iron supplementation (ferrous sulfate 200 mg once daily with vitamin C 500 mg) while simultaneously pursuing a comprehensive diagnostic work‑up to identify the underlying cause of anemia, with particular attention to nutritional deficiencies, chronic inflammation, and occult blood loss. 1

Immediate Laboratory Evaluation

• Complete iron panel (serum iron, TIBC, transferrin saturation, ferritin) should be obtained immediately to confirm iron deficiency and distinguish absolute from functional deficiency. 1
• Vitamin B12 and folate levels must be checked because protein‑calorie malnutrition frequently causes combined deficiencies that can mask microcytosis and impair hemoglobin response to iron therapy. 1, 2
• Inflammatory markers (C‑reactive protein, erythrocyte sedimentation rate) are essential because nursing‑home residents often have chronic inflammation that elevates ferritin independently of iron stores and impairs oral iron absorption. 1, 3
• Renal function tests (serum creatinine, estimated GFR) should be performed because chronic kidney disease is common in paraplegic patients and causes erythropoietin deficiency. 2
• Reticulocyte count helps differentiate inadequate marrow production (typical of CKD or nutritional deficiency) from blood loss or hemolysis. 2

The RDW of 15.5 % (elevated) combined with MCHC 31.6 g/dL (low‑normal) suggests early iron deficiency or a mixed nutritional deficiency. 4, 5

Diagnostic Interpretation Based on Iron Studies

If Ferritin < 30 ng/mL and TSAT < 20 % (Absolute Iron Deficiency)

• This confirms pure iron‑deficiency anemia requiring oral iron supplementation as first‑line therapy. 1
• Proceed with investigation for occult blood loss (see below). 1

If Ferritin 30–100 ng/mL with TSAT < 20 % and Elevated CRP

• This indicates combined iron deficiency and anemia of chronic disease, common in nursing‑home residents with pressure ulcers, chronic infections, or inflammatory conditions. 1, 3
• Oral iron may be attempted first, but intravenous iron should be considered if no hemoglobin rise occurs after 4 weeks. 1

If Ferritin > 100 ng/mL with TSAT < 20 % and Elevated CRP

• This defines functional iron deficiency where inflammation‑driven hepcidin traps iron in storage sites, making it unavailable for erythropoiesis. 1, 3
• Intravenous iron is first‑line therapy because oral iron cannot overcome hepcidin‑mediated intestinal blockade. 1

Investigation of Underlying Causes

Nutritional Assessment

• Protein‑calorie malnutrition is a major contributor to anemia in nursing‑home residents through multiple mechanisms: inadequate iron intake, impaired iron absorption, increased cytokine production causing inflammation, and deficiencies of B12, folate, and other micronutrients. 6, 7
• Dietary intake assessment should quantify daily caloric and protein intake; a minimum of 1700 kcal/day and 1.7 g/kg/day protein is necessary to maintain anabolism and support erythropoiesis. 7
• Oral nutritional supplements (ONS) providing at least 400 kcal/day including 30 g protein/day should be offered when dietary counseling and food fortification fail to meet nutritional goals. 6

Occult Blood Loss Evaluation

• Stool guaiac testing should be performed to screen for gastrointestinal bleeding. 1
• Bidirectional endoscopy (upper endoscopy + colonoscopy) is mandatory in men aged 65 years to exclude gastrointestinal malignancy, which may present solely with iron‑deficiency anemia. 1
• Medication review is essential because chronic NSAID use, aspirin, and proton‑pump inhibitors contribute to occult GI bleeding and impaired iron absorption. 1
• Paraplegic patients are at higher risk for pressure ulcers, which can cause chronic blood loss. 8

Chronic Kidney Disease Screening

• Paraplegic patients have increased risk of chronic kidney disease due to recurrent urinary tract infections, neurogenic bladder, and chronic inflammation. 2
• If eGFR < 60 mL/min/1.73 m², erythropoietin deficiency becomes a major contributor to anemia and may require erythropoiesis‑stimulating agents if iron repletion alone is insufficient. 2

Chronic Inflammation Assessment

• Nursing‑home residents frequently have chronic inflammatory conditions (pressure ulcers, recurrent infections, chronic wounds) that suppress erythropoiesis and induce functional iron deficiency via hepcidin elevation. 2, 7
• Elevated CRP confirms inflammation and mandates higher ferritin thresholds (≥ 100 ng/mL) to rule out iron deficiency. 3

Treatment Protocol

Oral Iron Therapy (First‑Line for Absolute Iron Deficiency)

• Ferrous sulfate 200 mg (≈ 65 mg elemental iron) once daily is the preferred first‑line treatment due to effectiveness and low cost. 1
• Co‑administer vitamin C 500 mg with each iron dose to enhance absorption, especially critical when transferrin saturation is low. 1
• Once‑daily dosing is superior to multiple daily doses because hepcidin remains elevated for ~48 hours after iron intake, blocking further absorption and increasing gastrointestinal side effects. 1
• Take on an empty stomach for optimal absorption; if gastrointestinal intolerance occurs, it may be taken with food. 1
• If ferrous sulfate is not tolerated, ferrous fumarate or ferrous gluconate are equally effective alternatives. 1

Expected Response and Monitoring

• Check hemoglobin at 4 weeks; an increase of ≈ 2 g/dL is expected with adequate therapy. 1
• Continue oral iron for 3 months after hemoglobin normalizes to fully replenish iron stores; total treatment duration is typically 6–7 months. 1
• Monitor hemoglobin and red‑cell indices every 3 months during the first year, then annually thereafter. 1

Indications for Switching to Intravenous Iron

• Intolerance to ≥ two different oral iron formulations (ferrous sulfate, fumarate, gluconate). 1
• Ferritin fails to improve after 4 weeks of compliant oral therapy. 1
• Hemoglobin fails to rise by ≥ 1 g/dL after 4 weeks despite adherence. 1
• Active inflammation with ferritin 100–300 ng/mL and TSAT < 20 % (functional iron deficiency). 1, 3
• Chronic kidney disease with eGFR < 30 mL/min/1.73 m² where oral iron is poorly absorbed. 1

Preferred Intravenous Iron Formulations

• Ferric carboxymaltose (750–1000 mg per 15‑minute infusion; two doses ≥ 7 days apart provide 1500 mg total) or ferric derisomaltose (1000 mg as a single infusion) are preferred because they replenish iron deficits in 1–2 sessions. 1
• All IV iron must be administered in a setting equipped with resuscitation facilities. 1

Nutritional Intervention

• Oral nutritional supplements should be continued for at least one month, with efficacy assessed monthly. 6
• Dietary counseling and food fortification should complement ONS to maximize dietary intake. 6
• Adequate protein and energy intake (minimum 1700 kcal/day and 1.7 g/kg/day protein) is necessary to reduce inflammation, improve iron absorption, and support erythropoiesis. 7

Vitamin B12 and Folate Supplementation

• If B12 or folate deficiency is confirmed, supplementation must be initiated immediately because combined deficiencies impair DNA synthesis and blunt hemoglobin response to iron therapy. 1, 2
• Low‑normal B12 may blunt hemoglobin response; consider B12 supplementation if hemoglobin fails to rise adequately after 4 weeks of iron therapy. 1

Critical Pitfalls to Avoid

• Do not prescribe multiple daily doses of oral iron; this increases side effects without improving efficacy due to hepcidin‑mediated absorption blockade. 1
• Do not discontinue iron therapy when hemoglobin normalizes; continue for an additional 3 months to restore iron stores. 1
• Do not persist with oral iron beyond 4 weeks without a hemoglobin rise; reassess for malabsorption, ongoing loss, inflammation, or need for IV iron. 1
• Do not overlook vitamin C supplementation when oral iron response is suboptimal. 1
• Do not rely solely on ferritin in the setting of chronic inflammation; both ferritin and TSAT must be interpreted together. 3
• Do not delay endoscopic evaluation in a 65‑year‑old male; gastrointestinal malignancy may present solely with iron‑deficiency anemia. 1
• Do not miss combined nutritional deficiencies (iron, B12, folate, protein) that are common in nursing‑home residents with malnutrition. 6, 7
• Do not attribute anemia solely to age; anemia always signifies an underlying disease requiring investigation. 9, 10, 11

Failure‑to‑Respond Algorithm

If anemia persists after 6 months of appropriate therapy:

• Verify adherence to oral iron and nutritional supplementation. 1
• Evaluate for ongoing blood loss (repeat stool guaiac, consider repeat endoscopy or video‑capsule endoscopy). 1
• Reassess for malabsorption syndromes (celiac disease, inflammatory bowel disease). 1
• Check for concurrent vitamin B12 or folate deficiency. 1
• Assess for chronic kidney disease requiring erythropoiesis‑stimulating agents. 2
• Consider hematology consultation for possible myelodysplastic syndrome or bone‑marrow pathology, especially if abnormalities in two or more cell lines are present. 2, 9